A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction of LY2216684 With Alcohol in Healthy Subjects.

Trial Profile

A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction of LY2216684 With Alcohol in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Sep 2011

At a glance

  • Drugs Edivoxetine (Primary)
  • Indications Depressive disorders
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 19 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Jul 2011 Planned end date changed from 1 Aug 2011 to 1 Sep 2011 as reported by ClinicalTrials.gov.
    • 08 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top